These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6452797)

  • 21. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT reuptake inhibitors plus tryptophan in endogenous depression.
    Wålinder J; Carlsson A; Persson R
    Acta Psychiatr Scand Suppl; 1981; 290():179-90. PubMed ID: 6452791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat.
    Fuxe K; Ogren SO; Agnati LF; Eneroth P; Holm AC; Andersson K
    Neurosci Lett; 1981 Jan; 21(1):57-62. PubMed ID: 6259561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of zimelidine and other antidepressant in conscious rats.
    Lindbom LO; Forsberg T
    Acta Psychiatr Scand Suppl; 1981; 290():380-4. PubMed ID: 6452801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of serotonin on memory impairments produced by ethanol.
    Weingartner H; Rudorfer MV; Buchsbaum MS; Linnoila M
    Science; 1983 Jul; 221(4609):472-4. PubMed ID: 6223371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine.
    von Knorring L; Johansson F
    Neuropsychobiology; 1980; 6(6):313-8. PubMed ID: 6449679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
    Saletu B; Grünberger J
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects.
    Saletu B; Grünberger J
    J Clin Psychiatry; 1988 Aug; 49 Suppl():59-71. PubMed ID: 2970456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-aggressive effect of zimelidine in isolated mice.
    Ogren SO; Holm AC; Renyi AL; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):71-4. PubMed ID: 6446833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat.
    de Montigny C; Blier P; Caillé G; Kouassi E
    Acta Psychiatr Scand Suppl; 1981; 290():79-90. PubMed ID: 6452807
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in saliva secretion and accommodation width during short-term administration of imipramine and zimelidine in healthy volunteers.
    von Knorring L
    Int Pharmacopsychiatry; 1981; 16(2):69-78. PubMed ID: 6460717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the novel 5-hydroxytryptamine reuptake inhibitor indalpine and ethanol on psychomotor performance.
    Seppälä T; Strömberg C; Mattila MJ
    Arzneimittelforschung; 1988 Jan; 38(1):98-102. PubMed ID: 3365283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.